ArticleClinics in orthopedic surgery2025
Clinical Benefits of Cartilage Repair in High Tibial Osteotomy Can Only Be Expected in Patients with Successfully Regenerated Cartilage.
Article in Clinics in orthopedic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Autologous collagen-induced chondrogenesis versus mesenchymal stem cell therapy combined with high tibial osteotomy for medial knee osteoarthritis: a retrospective study.Stem cell research & therapy · 2026Article
- Femoral Tunnel Position Thresholds Associated With Functional Outcomes After Medial Patellofemoral Ligament Reconstruction.Orthopaedic journal of sports medicine · 2026Article
- Combined Cartilage Procedures After High Tibial Osteotomy: Cartilage Status, Early Functional Recovery, and Short-term Clinical Outcomes.Orthopaedic journal of sports medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The clinical benefits of combining cartilage procedures with high tibial osteotomy (HTO) remain undetermined. This study aimed to evaluate the additional clinical benefits by comparing a combined procedure group with an isolated HTO group, with stratification based on the success of cartilage regeneration. Methods: Patients who underwent medial open-wedge HTO from 2010 to 2022 with a minimum 2-year follow-up were retrospectively reviewed. Patients were divided into 2 groups: HTO + combined cartilage procedures (C group) and isolated HTO (I group). C group was further divided into 2 subgroups based on the medial femoral condyle (MFC) cartilage status assessed on second-look arthroscopy: well-regenerated cartilage (C1 group) and poorly regenerated cartilage (C2 group). Propensity score-matched I groups were formed for each C1 and C2 group (C1-matched and C2-matched group I), based on baseline factors affecting clinical outcomes. Comparative analysis was performed for each matched pair based on patient-reported outcomes (PROs). Results: A total of 313 patients were retrospectively reviewed in this study, with 199 patients included in the analysis: 83 patients in the C group (49 in the C1 group and 34 in the C2 group) and 116 patients in the I group. Baseline characteristics showed no significant difference between the matched groups after propensity score matching. The mean follow-up period for all groups was approximately 3 years with no significant differences. The C1 group showed significantly better PROs and improved PROs at the final follow-up compared to the C1-matched I group (visual analog scale score, Conclusions: Only patients with well-regenerated cartilage after combined cartilage repair procedures showed additional clinical outcome improvements with HTO. When considering combined cartilage repair procedures with HTO, selecting appropriate candidates for achieving successful cartilage regeneration is necessary to yield additional clinical benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.